Ramipril increases the protein level of skeletal muscle IRS-1 and alters protein tyrosine phosphatase activity in spontaneously hypertensive rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 362, Issue 1, 2000, Pages 1-6

  Krützfeldt, Jan ^a   Raasch, Walter ^a   Klein, Harald H ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

ACE inhibition; Insulin receptor; IRS 1; Protein tyrosine phosphatases; Ramipril; Spontaneously hypertensive rats

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN P85; PROTEIN TYROSINE PHOSPHATASE; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; INSULIN BINDING; INSULIN SENSITIVITY; MALE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOTTING, WESTERN; INSULIN RESISTANCE; LIVER; MALE; MUSCLE, SKELETAL; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; RAMIPRIL; RATS; RATS, INBRED SHR; RECEPTOR, INSULIN;

EID: 0033931378     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000234     Document Type: Article

References (42)

1. Ahmad F, Goldstein BJ (1995) Alterations in specific protein-tyrosine phosphatase accompany insulin resistance of streptozotocin diabetes. Am J Physiol 268:E932-E940
2. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B 3rd, Johnson RS, Kahn CR (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
4. Brechler V, Reichlin S, De Gasparo M, Bottari SP (1994) Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism. Receptors Channels 2:89-98
5. Bunag RD, Tomita T, Sasaki S (1982) Streptozotocin diabetic rats are hypertensive despite reduced hypothalamic responsiveness. Hypertension 4:556-565
6. Caldiz CI, Cingolani GE de (1999) Insulin resistance in adipocytes from spontaneously hypertensive rats: effect of long-term treatment with enalapril and losartan. Metabolism 48:1041-1046
7. Campbell DJ, Kladis A, Duncan AM (1994) Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 23:439-449
8. Carvalho CR, Thirone AC, Gontijo JA, Velloso LA, Saad MJ (1997) Effect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes 46:1950-1957
9. Carvalho DS, Villaca V, Brenelli SL, Carvalho CR, Saad MJ (1998) Angiotensin-converting enzyme inhibitor increases insulin-induced pp 185 phosphorylation in liver and muscle of obese rats. Biochem Mol Biol Int 46:259-266
10. Chow L, De Gasparo M, Levens N (1995) Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors. Eur J Pharmacol 282:77-86
11. El-Dahr SS, Dipp S, Baricos WH (1998) Bradykinin stimulates the ERK→Elk-1→Fos/AP-1 pathway in mesangial cells. Am J Physiol 275:F343-F352
12. Ernsberger P, Ishizuka T, Liu S, Farrell CJ, Bedol D, Koletsky RJ, Friedman JE (1999) Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB). J Pharmacol Exp Ther 288:139-147
13. Fleming I, Busse R (1997) Tyrosine phosphorylation and braykinin-induced signaling in endothelial cells. Am J Cardiol 80: 102A-109A
14. Galletti F, Strazzullo P, Capaldo B, Carretta R, Fabris F, Ferrara LA, Glorioso N, Semplicini A, Mancini M (1999) Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS). J Hypertens 17:439-445
15. Goldstein BJ (1993) Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation. Receptor 3:1-15
16. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G (1997) Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 96:1173-1179
17. Hulman S, Falkner B, Freyvogel N (1993) Insulin resistance in the conscious spontaneously hypertensive rat: euglycemic hyperinsulinemic clamp study. Metabolism 42:14-18
18. Jacob S, Henriksen EJ, Fogt DL, Dietze GJ (1996) Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 45:535-541
19. Katayama S, Inaba M, Maruno Y, Morita T, Awata T, Oka Y (1997) Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: enhanced gene expression and synthesis of skeletal muscle glucose transporter 4. Hypertens Res 20:279-286
20. Klein HH, Kowalewski B, Drenckhan M, Fehm HL (1997) Insulin stimulation of human adipocytes activates the kinase of only a fraction of the insulin receptors. Am J Physiol 272:E576-E583
21. Kohara K, Brosnihan KB, Ferrario CM, Misted A (1992) Peripheral and central angiotensin II regulates expression of the reninangiotensin system. Am J Physiol 262:E651-E657
22. Kotzke G, Schutt M, Missler U, Moller DE, Fehm HL, Klein HH (1995) Binding of human, porcine and bovine insulin to insulin receptor from human brain, muscle and adipoctytes and to expressed recombinant alternatively spliced insulin receptor isoforms. Diabetologia 38:757-763
23. Krützfeldt J, Grünweller A, Raasch W, Drenckhan M, Klein HH (1999) Microtiter well assays for protein tyrosine phosphatase activities directed against phosphorylated insulin receptor or insulin receptor substrate-1. Anal Biochem 271:97-99
24. Kuhne MR, Zhao Z, Rowles J, Lavan BE, Shen SH, Fischer EH, Lienhard GE (1994) Dephosphorylation of insulin receptor substrate 1 by the tyrosine phosphatase PTP2C. J Biol Chem 269:15833-15837
25. Laemmli UK (1970) The cleavage of T4-Phage. Nature 227: 680-685
26. Leighton B, Sanderson AL, Young ME, Radda GK, Boehm EA, Clark JF (1996) Effects of treatment of spontaneously hypertensive rats with the angiotensin-converting enzyme inhibitor trandolapril and the calcium antagonist verapamil on the sensitivity of glucose metabolism to insulin in rat soleus muscle in vitro. Diabetes 45:120-124
27. Milarski KL, Saltiel AR (1994) Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J Biol Chem 269: 21239-21243
28. Myers MG Jr, Mendez R, Shi P, Pierce JH, Rhoads R, White MF (1998) The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling. J Biol Chem 273:26908-26914
29. Olichon-Berthe C, Hauguel-De Mouzon S, Peraldi P, Van Obberghen E, Le Marchand-Brustel Y (1994) Insulin receptor dephosphorylation by phosphotyrosine phosphatases obtained from insulin-resistant obese mice. Diabetologia 37:56-60
30. Reaven GM, Chang H, Hoffman BB, Azhar S (1989) Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats. Diabetes 39:1155-1160
31. Regitz-Zagrosek V, Auch-Schwelk W, Hess B, Klein U, Duske E, Steffen C, Hildebrandt AG, Fleck E (1995) Tissue-and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists. J Cardiovasc Pharmacol 26: 66-72
32. Rice KM, Garner CW (1994) Correlation of the insulin receptor substrate-1 with insulin-responsive deoxyglucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun 28:523-530
33. Takahasi K, Bardhan S, Kambayashi Y, Shirai H, Inagami T (1994) Protein tyrosine phosphatase inhibition by angiotensin II in rat pheochromocytoma cells through type 2 receptor, AT2. Biochem Biophys Res Commun 198:60-66
34. Tomiyama H, Kushiro T, Abeta H, Ishii T, Takahashi A, Furukawa L, Asagami T, Hino T, Saito F, Otsuka Y (1994) Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Hypertension 23:450-455
35. Tsuzuki S, Eguchi S, Inagami T (1996) Inhibition of cell proliferation and activation of protein tyrosine phosphatase mediated by angiotensin II type 2 (AT2) receptor in R3T3 cells. Biochem Biophys Res Commun 228:825-830
36. Uehara M, Kishikawa H, Isami S, Kisanuki K, Ohkubo Y, Mitamura N, Miyata Y, Yano T, Shichiri M (1994) Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 37:300-307
37. Ugi S, Maegawa H, Kashiwagi A, Adachi M, Olefski JM, Kikkawa R (1996) Expression of dominant negative mutant SHPTP2 attenuates phosphatidylinositol 3′-kinase activity via modulation of phosphorylation of insulin receptor substrate-1. J Biol Chem 271:12595-12602
38. Valensi P, Derobert E, Genthon R, Riou JP (1996) Effect of ramipril insulin sensitivity in obese patients. Time-course study of glucose infusion rate during euglycaemic hyperinsulinaemic clamp. Diabetes Metab 22:197-200
39. Virkamäki A, Ueki K, Kahn CR (1999) Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103:931-943
40. Vuorinen-Markkola H, Yki-Jarvinen H (1995) Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. Metabolism 44:85-89
41. Worm D, Handberg A, Hoppe E, Vinten J, Beck-Nielsen H (1996a) Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence. Diabetologia 39:142-148
42. Worm D, Vinten J, Staehr P, Henriksen JE, Handberg A, Beck-Nielsen H (1996b) Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects. Diabetologia 39:1208-1214